GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Global Health Clinics MJRX.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.40

—

Close of 4 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$47,771

FY2016FY2025

Net income

−C$1.3m

FY2016FY2025

Free cash flow

−C$572,206

FY2016FY2025

Shareholders' equity

−C$4.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$47,771C$82,960C$102,850C$146,810C$225,090C$352,140C$487,869———
Research and development———C$12,500C$42,000—————
Operating income−C$1.1m−C$1.1m−C$1.6m−C$1.5m−C$8.4m−C$1.7m−C$3.1m−C$3.1m−C$2.1m−C$31,920
Net income−C$1.3m−C$1.1m−C$1.6m−C$1.4m−C$8.5m−C$1.7m−C$16.3m−C$3.1m−C$2.1m−C$31,920
Diluted earnings per share-0.13-0.11-0.17-0.15-0.14-0.14-3.30-1.02-17.37-6.08

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$66,145C$29,330C$241,510C$578,810C$610,600C$563,848C$1.3mC$8.1mC$10.2mC$47,010
Cash and short-term investments—C$9,190C$214,340C$496,690C$456,260C$89,860C$922,280C$2.6mC$4.6m—
Total liabilitiesC$4.6mC$3.3mC$2.4mC$1.1mC$1.1mC$562,012C$489,393C$299,856C$400,692C$28,700
Debt——C$310,250C$322,320C$30,810C$27,450C$74,130—C$3,406C$770
Shareholders' equity−C$4.5m−C$3.3m−C$2.2m−C$559,580−C$440,390C$1,836C$785,244C$7.8mC$9.8mC$18,300
Shares outstanding9m9m9m9m62m12m5m3m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$572,206−C$496,550−C$1.0m−C$1.5m−C$825,799−C$903,285−C$3.1m−C$927,745−C$3.0m−C$12,492
Capital spending—————−C$55,000−C$15,000−C$15,000−C$15,000−C$15,000
Free cash flow−C$572,206−C$496,550−C$1.0m−C$1.5m−C$825,799−C$958,285−C$3.1m−C$942,745−C$3.0m−C$27,492

Latest quarters

By quarter end

Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024
RevenueC$3,232C$2,525C$2,105C$5,211C$8,840C$14,470C$19,250C$19,400
Operating income−C$253,459−C$263,816−C$263,836−C$293,516−C$311,890−C$315,580−C$281,770−C$300,911
Net income−C$331,136−C$337,652−C$332,790−C$356,140−C$311,890−C$315,580−C$281,770−C$333,148
Diluted earnings per share-0.04-0.04-0.04-0.04-0.03-0.03-0.03-0.04
Total assetsC$44,371C$52,879C$66,474C$66,145C$17,070C$49,330C$49,740C$29,328
Cash and short-term investments————C$4,860C$38,500C$37,940—
Debt————C$2.1mC$1.9mC$1.7m—
Shareholders' equity−C$5.5m−C$5.2m−C$4.9m−C$4.5m−C$4.2m−C$3.9m−C$3.5m−C$3.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-31.2%-32.9%—
Operating income-10.5%-9.2%13.9%
Net income-2.6%-5.8%13.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1632.3%-1374.5%-1598.9%—
Net margin-1792.7%-1403.3%-1620.8%—

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-0.1—
Price to sales1.20.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 11 Jul 2022
  • 10-to-1 reverse split · 22 May 2020
  • 5-to-1 reverse split · 4 May 2017
  • 5-to-1 reverse split · 21 May 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.